Immunome logo

Immunome Share Price Today

(NASDAQ: IMNM)

Immunome share price is $9.32 & ₹810.55 as on 6 Mar 2025, 2.30 'hrs' IST

$9.32

0.34

(3.79%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Immunome share price in Dollar and Rupees. Guide to invest in Immunome stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Immunome, along with analyst recommendations, forecasts, and comprehensive financials.

Immunome share price movements

  • Today's Low: $8.87
    Today's High: $9.32

    Day's Volatility :4.88%

  • 52 Weeks Low: $8.55
    52 Weeks High: $30.96

    52 Weeks Volatility :72.38%

Immunome (IMNM) Returns

PeriodImmunome IncIndex (Russel 2000)
3 Months
-29.29%
0.0%
6 Months
-36.85%
0.0%
1 Year
-65.91%
0.0%
3 Years
115.35%
-11.6%

Immunome (IMNM) Key Statistics

in dollars & INR

Previous Close
$8.98
Open
$8.98
Today's High
$9.32
Today's Low
$8.865
Market Capitalization
$757.0M
Today's Volume
$234.0K
52 Week High
$30.958
52 Week Low
$8.55
Revenue TTM
$10.1M
EBITDA
$-110.4M
Earnings Per Share (EPS)
$-7.93
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-276.36%

How to invest in Immunome Stock (IMNM) from India?

It is very easy for Indian residents to invest directly in Immunome from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Immunome stock in both Indian Rupees (INR) and US Dollars (USD). Search for Immunome or IMNM on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Immunome or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Immunome shares which would translate to 0.093 fractional shares of Immunome as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Immunome, in just a few clicks!

Returns in Immunome (IMNM) for Indian investors in Rupees

The Immunome stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Immunome investment value today

Current value as on today

₹40,346

Returns

₹59,654

(-59.65%)

Returns from Immunome Stock

₹64,617 (-64.62%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Immunome (IMNM)

-4%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Immunome Stock from India on INDmoney has decreased by -4% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Immunome

  • T. Rowe Price Investment Management,Inc.

    6.50%

  • Redmile Group, LLC

    5.70%

  • BlackRock Inc

    4.87%

  • FMR Inc

    4.63%

  • EcoR1 Capital, LLC

    4.58%

  • Enavate Sciences GP, LLC

    4.11%

Analyst Recommendation on Immunome

Buy

    90%Buy

    9%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Immunome(by analysts ranked 0 to 5 stars)

Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
8
8
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Immunome Stock (IMNM)

What analysts predicted

Upside of 221.89%

Target:

$30.00

Current:

$9.32

Insights on Immunome Stock (Ticker Symbol: IMNM)

  • Price Movement

    In the last 1 month, IMNM stock has moved down by -24.1%
  • IMNM vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 126.6%
  • Price to Sales

    ForIMNM every $1 of sales, investors are willing to pay $47.5, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

Immunome Technicals Summary

Sell

Neutral

Buy

Immunome is currently in a neutral trading position according to technical analysis indicators.

Immunome (IMNM) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Immunome Inc logo
-18.95%
-36.85%
-65.91%
115.35%
-33.23%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Immunome Inc logo
NA
NA
NA
-4.16
-2.76
-0.4
NA
3.56
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Immunome Inc logo
Buy
$757.0M
-33.23%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Immunome

Immunome, Inc., a biotechnology company, develops targeted cancer therapies. The company's clinical asset comprises AL102, an investigational gamma secretase inhibitor currently in evaluation in a Phase 3 trial for the treatment of desmoid tumors; and preclinical assets consist of IM-1021, a receptor tyrosine kinase-like orphan receptor 1 and antibody-drug conjugates, as well as IM-3050, a fibroblast activation protein targeted radioligand therapy; and IM-4320, an anti-IL-38 immunotherapy candidate. Immunome, Inc. was incorporated in 2006 and is based in Bothell, Washington.
Organization
Immunome
Employees
105
CEO
Dr. Clay B. Siegall Ph.D.
Industry
Health Technology

Management People of Immunome

NameTitle
Dr. Clay B. Siegall Ph.D.
President, CEO & Chairman
Dr. Jack Higgins Ph.D.
Chief Scientific Officer
Dr. Robert J. Lechleider M.D.
Chief Medical Officer
Mr. Max Rosett
Executive VP of Operations, Principal Accounting & Financial Officer and CFO
Dr. Philip Tsai
Chief Technical Officer
Ms. Sandra G. Stoneman Esq., J.D.
Chief Legal Officer, General Counsel & Corporate Secretary
Mr. Kinney Horn
Chief Business Officer
Mr. Roee Shahar
Executive Vice President of Commercial

Important FAQs about investing in IMNM Stock from India :

What is Immunome share price today?

Immunome share price today stands at $9.32, Open: $8.98 ; Previous Close: $8.98 ; High: $9.32 ; Low: $8.87 ; 52 Week High: $30.96 ; 52 Week Low: $8.55.

The stock opens at $8.98, after a previous close of $8.98. The stock reached a daily high of $9.32 and a low of $8.87, with a 52-week high of $30.96 and a 52-week low of $8.55.

Can Indians buy Immunome shares?

Yes, Indians can invest in the Immunome (IMNM) from India.

With INDmoney, you can buy Immunome at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Immunome at zero transaction cost.

How can I buy Immunome shares from India?

It is very easy to buy Immunome from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Immunome (IMNM) be purchased?

Yes, you can buy fractional shares of Immunome with INDmoney app.

What are the documents required to start investing in Immunome stocks?

To start investing in Immunome, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Immunome Stock (IMNM)?

Today’s highest price of Immunome (IMNM) is $9.32.

Today’s lowest price of Immunome (IMNM) is $8.87.

What is today's market capitalisation of Immunome?

Today's market capitalisation of Immunome IMNM is 757.0M

What is the 52 Week High and Low Range of Immunome Stock (IMNM)?

  • 52 Week High

    $30.96

  • 52 Week Low

    $8.55

What are the historical returns of Immunome (IMNM)?

  • 1 Month Returns

    -18.95%

  • 3 Months Returns

    -36.85%

  • 1 Year Returns

    -65.91%

  • 5 Years Returns

    -33.23%

Who is the Chief Executive Officer (CEO) of Immunome ?

Dr. Clay B. Siegall Ph.D. is the current Chief Executive Officer (CEO) of Immunome.